NCT03027037

Brief Summary

This study, funded by the John Templeton Foundation, will examine birth and the early postpartum period (BEPP) as a transformative life experience that may shift women's experience of emotion in such ways as to a) support enhanced other-oriented emotions and b) underlie risk or resilience from psychopathology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 20, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

March 31, 2020

Status Verified

March 1, 2020

Enrollment Period

2.2 years

First QC Date

January 17, 2017

Last Update Submit

March 27, 2020

Conditions

Outcome Measures

Primary Outcomes (7)

  • Occurrence of mood episodes and anxiety disorders

    Assessed via interview

    Throughout study (pregnancy to 6 months postpartum)

  • Mood and anxiety symptoms

    Assessed via questionnaires

    Throughout study (pregnancy to 6 months postpartum)

  • Emotion reactivity and regulation

    Assessed via questionnaires, experimental tasks, and physiological measurement

    Throughout study (pregnancy to 6 months postpartum)

  • Empathic accuracy

    Assessed via experimental tasks

    Throughout study (pregnancy to 6 months postpartum)

  • Prosocial behavior

    Assessed via questionnaires and experimental tasks

    Throughout study (pregnancy to 6 months postpartum)

  • Well-being and social support

    Assessed via questionnaires

    Throughout study (pregnancy to 6 months postpartum)

  • Parenting sensitivity, efficacy, stress, bond with infant

    Assessed via questionnaires and behavioral observation

    Throughout study (pregnancy to 6 months postpartum)

Study Arms (2)

Remitted Major Depression Group

Women in this group will have experienced at least one episode of major depression in their lifetime, but no episodes in the two months prior to study enrollment.

Control Group

Women in this group will never have experienced any Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Axis I psychological disorder.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will include up to 200 pregnant adult women over the age of 18 across the United States. Two roughly equal groups of participants will be recruited: women with a history of major depressive disorder, currently in remission (MDD) and healthy controls with no current or lifetime history of mental illness (CTL).

You may qualify if:

  • Over age 18
  • Female
  • Currently pregnant - approximately no more than 34 weeks gestational age
  • Able to read and write in English fluently
  • MDD Group: Meet DSM-IV/DSM-5 criteria for at least 1 past episode of Major Depressive Disorder
  • MDD Group: DO NOT meet DSM-IV/DSM-5 criteria for any episodes of Major Depressive Disorder in past 2 months (currently in symptom remission)

You may not qualify if:

  • Previous birth to a living child (i.e., this pregnancy is not their first child)
  • Imminently suicidal or homicidal
  • History of severe head trauma, stroke, neurological disease
  • History of brain tumors or surgery
  • Severe medical illness (e.g., autoimmune disorder, blindness, cardiovascular disease, HIV/AIDS)
  • Endocrine disorders (e.g., Cushing's disease, thyroid disorder)
  • Alcohol/substance abuse or dependence within the past six months
  • Current psychotic episode (impairing ability to consent, participate, or keep patient and experimenter safe)
  • Inability to follow study procedures
  • CTL Group: Current or lifetime Axis I disorder (i.e., anxiety disorders, major depression, mania/hypomania, dysthymia, schizophrenia, schizoaffective disorder, substance abuse/dependence, eating disorders, hypochondriasis, pain disorder, or adjustment disorders)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Boulder

Boulder, Colorado, 80309, United States

Location

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Sona Dimidjian, PhD

    University of Colorado, Boulder

    PRINCIPAL INVESTIGATOR
  • June Gruber, PhD

    University of Colorado, Boulder

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Director

Study Record Dates

First Submitted

January 17, 2017

First Posted

January 20, 2017

Study Start

November 1, 2015

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

March 31, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations